glp 1 news today Use and misuse of GLP-1 receptor agonists were common in people with eating disorders, interim results of an ongoing cross-sectional study suggested. Among over 400 people with eating disorders in an interim GLP-1 Pipeline Update: November 2025

Instead, these FDA-approved medications work primarily by reducing appetite, slowing gastric emptying, and decreasing caloric intake

Mercy Ointment 5.00 Glutathione Comprime Super Fort Strong Whitening Face Cream 18.00 Creme Glutathione Comprime Face Cream Super Eclaircissant 30g is a whitening facial cream, its anti-tach, anti acne and freckles

RETATRUTIDE (RETA) Third-Party Tested COA Available Retatrutide is a synthetic peptide engineered to interact with multiple metabolic receptor systems including GLP-1, GIP, and glucagon receptors

In addition, a 1- or 2-step DOC can be considered for properly selected low-risk patients

This date was later rescheduled

CNS: central nervous system EGCG is a potent bioactive compound that significantly impacts antioxidant and anti-inflammatory biological pathways